Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Her Royal Highness, the Duchess of Cornwall opened Phase II of the Institute of Musculoskeletal Sciences, Botnar Research Centre.

Her Royal Highness, the Duchess of Cornwall, came to the Botnar Research Centre on 9 May to officially open the Phase II building of the Institute of Musculoskeletal Sciences. She is a patron of the Nuffield Orthopaedic Centre Charity, which supports the hospitalwhere the Institute is based, and also opened the Phase I building in 2003.

Professor Andrew Carr, departmental head of NDORMS, noted that: "The Botnar Research Centre brings the University's bone, joint and arthritis research together in a purpose-built facility on the site of the Nuffield Orthopaedic Centre. This allows truly multidisciplinary science right where patients are, offering a partnership between University research and teaching and the work that goes on in NHS clinical practice at the hospital, with many patients participating in research projects and clinical studies."

Further information and pictures from the visit can be found on the University website.

Similar stories

Small mechanical forces in immune cells measured at unprecedented sensitivity

Kennedy Main Research

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.